{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:38:43Z","timestamp":1790775523935,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pericytes represent important support cells surrounding microvessels found in solid organs. Emerging evidence points to their involvement in tumor progression and metastasis. Although reported to be present in the human lung, their specific presence and functional orientation within the tumor microenvironment in non-small cell lung cancer (NSCLC) has not yet been adequately studied. Using a multiparameter approach, we prospectively identified, sorted and expanded mesenchymal cells from human primary NSCLC samples based on co-expression of CD73 and CD90 while lacking hematopoietic and endothelial lineage markers (CD45, CD31, CD14 and Gly-A) and the epithelial marker EpCAM. Compared to their normal counterpart, tumor-derived Lineage-EpCAM-CD73+CD90+ cells showed enhanced expression of the immunosuppressive ligand PD-L1, a higher constitutive secretion of IL-6 and increased basal \u03b1SMA levels. In an <jats:italic>in vitro<\/jats:italic> model of 3D microvessels, both tumor-derived and matched normal Lineage-EpCAM-CD73+CD90+ cells supported the assembly of perfusable vessels. However, tumor-derived Lineage-EpCAM-CD73+CD90+ cells led to the formation of vessels with significantly increased permeability. Together, our data show that perivascular-like cells present in NSCLC retain functional abnormalities <jats:italic>in vitro<\/jats:italic>. Perivascular-like cells as an eventual target in NSCLC warrants further investigation.<\/jats:p>","DOI":"10.1038\/s41598-017-09928-1","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T10:22:02Z","timestamp":1504174922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model"],"prefix":"10.1038","volume":"7","author":[{"given":"Colette A.","family":"Bichsel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laur\u00e8ne","family":"Froment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-9791","authenticated-orcid":false,"given":"Sabina","family":"Berezowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Wang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Geiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1103-9712","authenticated-orcid":false,"given":"Olivier T.","family":"Guenat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-7329","authenticated-orcid":false,"given":"Sean R. R.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,6]]},"reference":[{"key":"9928_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/cam.20377","volume":"6","author":"M Otranto","year":"2012","unstructured":"Otranto, M. et al. The role of the myofibroblast in tumor stroma remodeling. Cell Adhes. Migr. \n                           6, 203\u2013219 (2012).","journal-title":"Cell Adhes. Migr."},{"key":"9928_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2009.10.001","volume":"21","author":"TA Gonda","year":"2010","unstructured":"Gonda, T. A., Varro, A., Wang, T. C. & Tycko, B. Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy? Semin. Cell Dev. Biol. \n                           21, 2\u201310 (2010).","journal-title":"Semin. Cell Dev. Biol."},{"key":"9928_CR3","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","volume":"18","author":"M Egeblad","year":"2010","unstructured":"Egeblad, M., Nakasone, E. S. & Werb, Z. Tumors as organs: Complex tissues that interface with the entire organism. Dev. Cell \n                           18, 884\u2013901 (2010).","journal-title":"Dev. Cell"},{"key":"9928_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature \n                           501, 346\u2013354 (2013).","journal-title":"Nature"},{"key":"9928_CR5","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1002\/stem.187","volume":"27","author":"S Kidd","year":"2009","unstructured":"Kidd, S. et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells \n                           27, 2614\u20132623 (2009).","journal-title":"Stem Cells"},{"key":"9928_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan, D. & Coussens, L. M. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment. Cancer Cell \n                           21, 309\u2013322 (2012).","journal-title":"Cancer Cell"},{"key":"9928_CR7","doi-asserted-by":"crossref","unstructured":"Lin, S.-L., Kisseleva, T., Brenner, D. A. & Duffield, J. S. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617\u20131627 (2008).","DOI":"10.2353\/ajpath.2008.080433"},{"key":"9928_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","volume":"176","author":"BD Humphreys","year":"2010","unstructured":"Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. \n                           176, 85\u201397 (2010).","journal-title":"Am. J. Pathol."},{"key":"9928_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/0026-2862(74)90096-X","volume":"8","author":"ER Weibel","year":"1974","unstructured":"Weibel, E. R. On pericytes, particularly their existence on lung capillaries. Microvasc. Res. \n                           8, 218\u201335 (1974).","journal-title":"Microvasc. Res."},{"key":"9928_CR10","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1164\/rccm.201212-2297OC","volume":"188","author":"C Hung","year":"2013","unstructured":"Hung, C. et al. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. \n                           188, 820\u201330 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"9928_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mvr.2006.03.002","volume":"71","author":"RG Bagley","year":"2006","unstructured":"Bagley, R. G. et al. Pericytes from human non-small cell lung carcinomas: An attractive target for anti-angiogenic therapy. Microvasc. Res. \n                           71, 163\u2013174 (2006).","journal-title":"Microvasc. Res."},{"key":"9928_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik, A., Genov\u00e9, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell \n                           21, 193\u2013215 (2011).","journal-title":"Dev. Cell"},{"key":"9928_CR13","first-page":"909","volume":"24","author":"L Diaz-Flores","year":"2009","unstructured":"Diaz-Flores, L. et al. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol. Histopathol. \n                           24, 909\u2013969 (2009).","journal-title":"Histol. Histopathol."},{"key":"9928_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ajh.21745","volume":"85","author":"A Raza","year":"2010","unstructured":"Raza, A., Franklin, M. J. & Dudek, A. Z. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am. J. Hematol. \n                           85, 593\u2013598 (2010).","journal-title":"Am. J. Hematol."},{"key":"9928_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nm0603-685","volume":"9","author":"RK Jain","year":"2003","unstructured":"Jain, R. K. Molecular regulation of vessel maturation. Nat. Med. \n                           9, 685\u201393 (2003).","journal-title":"Nat. Med."},{"key":"9928_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0002-9440(10)64920-6","volume":"160","author":"S Morikawa","year":"2002","unstructured":"Morikawa, S. et al. Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors. Am. J. Pathol. \n                           160, 985\u20131000 (2002).","journal-title":"Am. J. Pathol."},{"key":"9928_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/sonc.2002.37263","volume":"29","author":"J Folkman","year":"2002","unstructured":"Folkman, J. Role of angiogenesis in tumor growth and metastasis. Seminars in oncology \n                           29, 15\u201318 (2002).","journal-title":"Seminars in oncology"},{"key":"9928_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.celrep.2015.01.035","volume":"10","author":"D Keskin","year":"2015","unstructured":"Keskin, D. et al. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2. Cell Rep. \n                           10, 1066\u201381 (2015).","journal-title":"Cell Rep."},{"key":"9928_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv209","volume":"107","author":"J Hong","year":"2015","unstructured":"Hong, J. et al. Role of tumor pericytes in the recruitment of myeloid-derived suppressor cells. J Natl Cancer Inst. \n                           107, djv209 (2015).","journal-title":"J Natl Cancer Inst."},{"key":"9928_CR20","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1089\/ten.tea.2014.0545","volume":"21","author":"CA Bichsel","year":"2015","unstructured":"Bichsel, C. A., Hall, S. R. R., Schmid, R. A., Guenat, O. T. & Geiser, T. Primary human lung pericytes support and stabilize in vitro perfusable microvessels. Tissue Eng. Part A \n                           21, 2166\u20132176 (2015).","journal-title":"Tissue Eng. Part A"},{"key":"9928_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","volume":"97","author":"A Armulik","year":"2005","unstructured":"Armulik, A., Abramsson, A. & Betsholtz, C. Endothelial\/pericyte interactions. Circ. Res. \n                           97, 512\u201323 (2005).","journal-title":"Circ. Res."},{"key":"9928_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes, R. M. et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J. Thorac. Oncol. \n                           6, 209\u2013217 (2011).","journal-title":"J. Thorac. Oncol."},{"key":"9928_CR23","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1073\/pnas.0709663105","volume":"105","author":"FA High","year":"2008","unstructured":"High, F. A. et al. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad Sci USA \n                           105, 1955\u20131959 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"9928_CR24","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/ATVBAHA.111.232934","volume":"31","author":"E Boscolo","year":"2011","unstructured":"Boscolo, E. et al. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte\/vascular smooth muscle cell differentiation. Arterioscler. Thromb. Vasc. Biol. \n                           31, 2181\u20132192 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"9928_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1215\/S1152851705000232","volume":"7","author":"G Bergers","year":"2005","unstructured":"Bergers, G. & Song, S. The role of pericytes in blood-vessel formation and maintenance. Neuro. Oncol. \n                           7, 452\u2013464 (2005).","journal-title":"Neuro. Oncol."},{"key":"9928_CR26","first-page":"5381","volume":"62","author":"DM Mcdonald","year":"2002","unstructured":"Mcdonald, D. M. & Baluk, P. Significance of blood vessel leakiness in cancer. Cancer Res. \n                           62, 5381\u20135 (2002).","journal-title":"Cancer Res."},{"key":"9928_CR27","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-13-2613","volume":"20","author":"L Li","year":"2014","unstructured":"Li, L. et al. Metformin sensitizes EGFR-TKI-Resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. Clin. Cancer Res. \n                           20, 2714\u20132726 (2014).","journal-title":"Clin. Cancer Res."},{"key":"9928_CR28","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1158\/0008-5472.CAN-15-2840","volume":"76","author":"MS Caetano","year":"2016","unstructured":"Caetano, M. S. et al. IL-6 blockade reprograms the lung tumor microenvironment to limit the development and progression of K-ras mutant lung cancer. Cancer Res. \n                           76, 3189\u201399 (2016).","journal-title":"Cancer Res."},{"key":"9928_CR29","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1172\/JCI34237","volume":"117","author":"ZT Schafer","year":"2007","unstructured":"Schafer, Z. T. & Brugge, J. S. IL-6 involvement in epithelial cancers. J. Clin. Invest. \n                           117, 3660\u20133663 (2007).","journal-title":"J. Clin. Invest."},{"key":"9928_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0030-1253452","volume":"36","author":"CD Ochoa","year":"2010","unstructured":"Ochoa, C. D., Wu, S. & Stevens, T. New Developments in Lung Endothelial Heterogeneity: von Willebrand factor, P-selectin, and the Weibel-Palade Body. Semin Thromb Hemost \n                           36, 301\u2013308 (2010).","journal-title":"Semin Thromb Hemost"},{"key":"9928_CR31","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jtho.2016.04.007","volume":"11","author":"J-M Sun","year":"2016","unstructured":"Sun, J.-M. et al. Prognostic significance of programmed cell death ligand 1 in patients with non\u2013small-cell lung cancer: A large cohort study of surgically resected cases. J. Thorac. Oncol. \n                           11, 1003\u201311 (2016).","journal-title":"J. Thorac. Oncol."},{"key":"9928_CR32","doi-asserted-by":"publisher","first-page":"19738","DOI":"10.18632\/oncotarget.7582","volume":"7","author":"F Passiglia","year":"2016","unstructured":"Passiglia, F. et al. PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis. Oncotarget \n                           7, 19738\u201347 (2016).","journal-title":"Oncotarget"},{"key":"9928_CR33","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1158\/0008-5472.CAN-15-1227","volume":"75","author":"G Gopinathan","year":"2015","unstructured":"Gopinathan, G. et al. Interleukin-6 stimulates defective angiogenesis. Cancer Res. \n                           75, 3098\u20133107 (2015).","journal-title":"Cancer Res."},{"key":"9928_CR34","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","volume":"14","author":"DJJ Waugh","year":"2008","unstructured":"Waugh, D. J. J. & Wilson, C. The interleukin-8 pathway in cancer. Clin. Cancer Res. \n                           14, 6735\u20136741 (2008).","journal-title":"Clin. Cancer Res."},{"key":"9928_CR35","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","volume":"170","author":"A Li","year":"2003","unstructured":"Li, A., Dubey, S., Varney, M. L., Bhavana, J. & Singh, R. K. IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis. J Immunol. \n                           170, 3369\u20133376 (2003).","journal-title":"J Immunol."},{"key":"9928_CR36","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell \n                           144, 646\u201374 (2011).","journal-title":"Cell"},{"key":"9928_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nm.3028","volume":"19","author":"P Bianco","year":"2013","unstructured":"Bianco, P. et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. \n                           19, 35\u201342 (2013).","journal-title":"Nat. Med."},{"key":"9928_CR38","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu, V. S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. \n                           19, 1047\u201353 (2013).","journal-title":"Nat. Med."},{"key":"9928_CR39","doi-asserted-by":"publisher","first-page":"E1475","DOI":"10.1073\/pnas.1117988108","volume":"108","author":"JS Rock","year":"2011","unstructured":"Rock, J. S. et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA \n                           108, E1475\u201383 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"9928_CR40","doi-asserted-by":"publisher","first-page":"E7551","DOI":"10.1073\/pnas.1600363113","volume":"113","author":"A Arina","year":"2016","unstructured":"Arina, A. et al. Tumor-associated fibroblasts predominantly come from local and not circulating precursors. Proc Natl Acad Sci USA \n                           113, E7551\u20136 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"9928_CR41","doi-asserted-by":"publisher","first-page":"E5618","DOI":"10.1073\/pnas.1608384113","volume":"113","author":"K Hosake","year":"2016","unstructured":"Hosake, K. et al. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci USA \n                           113, E5618\u201327 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"9928_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.stem.2008.08.008","volume":"3","author":"AI Caplan","year":"2008","unstructured":"Caplan, A. I. All MSCs Are Pericytes? Cell Stem Cell \n                           3, 229\u2013230 (2008).","journal-title":"Cell Stem Cell"},{"key":"9928_CR43","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ncb3228","volume":"17","author":"MG Procopio","year":"2015","unstructured":"Procopio, M. G. et al. Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. Nat. Cell Biol. \n                           17, 1193\u2013204 (2015).","journal-title":"Nat. Cell Biol."},{"key":"9928_CR44","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/cr.2015.51","volume":"25","author":"P Li","year":"2015","unstructured":"Li, P. et al. Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2\/interleukin-6 signaling in the tumor microenvironment. Cell Res. \n                           25, 588\u2013603 (2015).","journal-title":"Cell Res."},{"key":"9928_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cll.2007.05.001","volume":"27","author":"JW Tung","year":"2007","unstructured":"Tung, J. W. et al. Modern flow cytometry: a practical approach. Clin. Lab. Med. \n                           27, 453\u2013468 (2007).","journal-title":"Clin. Lab. Med."},{"key":"9928_CR46","doi-asserted-by":"crossref","unstructured":"Herzenberg, L. A., Tung, J., Moore, W. A., Herzenberg, L. A. & Parks, D. R. Interpreting flow cytometry data: a guide for the perplexed. Nat. Immunol. 7, 681\u2013685 (2006).","DOI":"10.1038\/ni0706-681"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09928-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09928-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09928-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:23:30Z","timestamp":1671791010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09928-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["9928"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-09928-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,6]]},"assertion":[{"value":"27 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10636"}}